Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
FDA Approves Treatment for Thrombocytopenia
12/14/2018
The FDA approved romiplostim for the treatment of immune thrombocytopenia in children 1 year of age and older who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
The FDA approved romiplostim for the treatment of immune thrombocytopenia in children 1 year of age and older who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
The FDA approved romiplostim for...
12/14/2018
Oncology
News
Long-Term Estrogen Use Tied to Breast Cancer Risk
11/26/2018
Postmenopausal women who take estrogen therapy for long periods of time may have a significantly increased risk of breast cancer, a new study suggests.
Postmenopausal women who take estrogen therapy for long periods of time may have a significantly increased risk of breast cancer, a new study suggests.
Postmenopausal women who take...
11/26/2018
Pharmacy Learning Network

Advertisement

News
More Young Kids Allergic to Milk Than Peanuts, but Less Likely to Carry Epinephrine
11/23/2018
"Given that epinephrine is the only FDA-approved first-line therapy for a severe food allergic reaction, this suggests that there remains room for improvement at the provider-level," researchers said. 
"Given that epinephrine is the only FDA-approved first-line therapy for a severe food allergic reaction, this suggests that there remains room for improvement at the provider-level," researchers said. 
"Given that epinephrine is the...
11/23/2018
Pharmacy Learning Network
News
Heart Attack Patients are Getting Younger
11/23/2018
Young adults, especially young women, make up an increasing proportion of patients hospitalized with acute myocardial infarction, according to recent study results. 
Young adults, especially young women, make up an increasing proportion of patients hospitalized with acute myocardial infarction, according to recent study results. 
Young adults, especially young...
11/23/2018
Pharmacy Learning Network
News
Hyperglycemia Management Should Include Focus on Lifestyle, Obesity, Concurrent Diseases
11/22/2018
The management of hyperglycemia in patients with type 2 diabetes should include attention to lifestyle, diabetes self-management, obesity and cardiovascular and other concurrent diseases, according to a recent report. 
The management of hyperglycemia in patients with type 2 diabetes should include attention to lifestyle, diabetes self-management, obesity and cardiovascular and other concurrent diseases, according to a recent report. 
The management of hyperglycemia...
11/22/2018
Pharmacy Learning Network

Advertisement

News
FDA Warning: Stopping Treatment Severely Worsens MS
11/21/2018
According to the FDA, patients with multiple sclerosis will experience severe worsening of their disease if they stop treatment.
According to the FDA, patients with multiple sclerosis will experience severe worsening of their disease if they stop treatment.
According to the FDA, patients...
11/21/2018
Pharmacy Learning Network
News
Two Studies Find Probiotic Therapy Ineffective Against Stomach Flu, Diarrhea
11/21/2018
A widely-used probiotic therapy is ineffective against the diarrhea, vomiting and abdominal pain of gastroenteritis, two large studies have concluded.
A widely-used probiotic therapy is ineffective against the diarrhea, vomiting and abdominal pain of gastroenteritis, two large studies have concluded.
A widely-used probiotic therapy...
11/21/2018
Pharmacy Learning Network
News
Antibiotic Recalled
11/21/2018
Over 23,000 bottles of an antibiotic are being recalled. 
Over 23,000 bottles of an antibiotic are being recalled. 
Over 23,000 bottles of an...
11/21/2018
Pharmacy Learning Network

Advertisement

News
UTI Drug Recalled
11/21/2018
The FDA is recalling a prescription antibiotic used to treat urinary tract infections caused by certain bacteria.
The FDA is recalling a prescription antibiotic used to treat urinary tract infections caused by certain bacteria.
The FDA is recalling...
11/21/2018
Pharmacy Learning Network
News
Heart Drug Recalled
11/21/2018
A prescription nitrate used to prevent chest pain in patients with coronary artery disease is being recalled.
A prescription nitrate used to prevent chest pain in patients with coronary artery disease is being recalled.
A prescription nitrate used to...
11/21/2018
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use